COMMUNIQUÉS West-GlobeNewswire

Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer
02/12/2025
Positive feedback reinforces Silexion’s trajectory toward its planned Phase 2/3 trial initiation in Q2 2026 Company plans to complete regulatory submissions to the Israeli Ministry of Health by the end of Q4 2025 and in [...]
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
02/12/2025
Woodland, CA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTC: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, today announced it has entered into a formal teaming agreement with [...]
Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
02/12/2025
AGOURA HILLS, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano , a clinical-stage nanomedicine company, today announced new data demonstrating that [...]
Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
02/12/2025
DURHAM, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos [...]
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
02/12/2025
— New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitug in PSC and Supports Advancement to a P hase 3 Registration Trial — TEL AVIV, Israel, Dec. 02, [...]
AnewHealth Names Ken Burdick Chairman of Board of Directors
02/12/2025
With decades of experience and expertise in healthcare, Burdick will support AnewHealth in a strategic capacity as the organization advances on its mission of delivering transformative pharmacy solutions CLEVELAND, OH [...]
HealthLynked Expands Board of Directors With Addition of Two Leading Insurance Executives: Chris G. Pulos of Marsh McLennan and Jason Bishara of NSI Insurance
02/12/2025
NAPLES, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), an AI-driven global healthcare network focused on improving care coordination and reducing healthcare costs, today announced [...]
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.
02/12/2025
Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companies Strong track record of launching breakthrough technologies across spine [...]
Alberta Cancer Foundation launches 'The Time Store' campaign to bring more moments to Albertans facing cancer
02/12/2025
Province-wide campaign asks Albertans to give more meaningful moments for people like patient Colin Dalziel EDMONTON, Alberta, Dec. 02, 2025 (GLOBE NEWSWIRE) -- This Giving Tuesday and throughout the holiday season, [...]
The Ensign Group Adds Real Estate and Operations in Kansas
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Increases Operations in Arizona
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Grows Operations in Colorado
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth
02/12/2025
Berlin, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tacalyx, a privately held biotech company focused on developing novel TACA (Tumour Associated Carbohydrate Antigens) cancer therapies, announces the appointment of Jean [...]
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
02/12/2025
The collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain Clients to benefit from accelerated timelines, as well as reduced [...]
Vandria Reports Positive Phase 1 Target Engagement Data for VNA-318, Supporting Further Development in Alzheimer’s Disease
02/12/2025
Results presented at the 18th Clinical Trials in Alzheimer's Disease (CTAD) meeting, San Diego, December 1-4 VNA-318, an oral brain-penetrant small molecule therapeutic modulates a novel target to reduce inflammation [...]
CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia
02/12/2025
Clermont-Ferrand (France), 2 December 2025 (8:45 AM CET). In line with the commitment signed on November 6, 2025 1 , CARBIOS (Euronext Growth Paris: ALCRB) and Wankai New Materials (« Wankai »), a listed subsidiary 2 of [...]
CARBIOS et Wankai New Materials signent l’accord définitif constitutif d’un partenariat stratégique pour déployer à très grande échelle la technologie de biorecyclage du PET de CARBIOS en Asie
02/12/2025
Clermont-Ferrand (France), 2 décembre 2025 (08h45 CET). Conformément à l’engagement signé le 6 novembre 2025 1 , CARBIOS (Euronext Growth Paris : ALCRB) et Wankai New Materials (« Wankai »), une filiale cotée 2 du [...]
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
02/12/2025
EO2401 in vivo immune therapy + nivolumab +/- bevacizumab shows survival benefit in first recurrent glioblastoma Data presented at 2025 SNO conference by lead investigator Paris, France – 2 DECEMBER 2025 (08:30 CET) [...]
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
02/12/2025
COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 months. This [...]

Pages